Skip to main content
. 2007 Nov 26;5:60. doi: 10.1186/1479-5876-5-60

Figure 3.

Figure 3

Overall survival of patients enrolled in the study. Positive indicates patients who had evidence of the development of a carcinoembryonic antigen (CEA)- and/or mucin-1 (MUC-1)-specific immune response. Negative indicates patients who did not develop an immune response (n = 3) or who were not assayed (n = 2).